Neumora Therapeutics, Inc. (NMRA)
1.77
-0.01
(-0.56%)
USD |
NASDAQ |
Dec 30, 16:00
1.77
0.00 (0.00%)
After-Hours: 07:44
Neumora Therapeutics EPS Diluted (Quarterly): -0.3507 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Puma Biotechnology, Inc. | 0.1736 |
| Ventyx Biosciences, Inc. | -0.3202 |
| MapLight Therapeutics, Inc. | -0.6484 |
| CEL-SCI Corp. | -0.7611 |
| AIM ImmunoTech, Inc. | -1.569 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -56.76M |
| Total Expenses (Quarterly) | 56.76M |
| Enterprise Value | 144.31M |
| Earnings Yield | -82.67% |
| Normalized Earnings Yield | -81.45 |